Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy

Vaccine

Volumn 24, Issue 21, 2006, Pages 4461-4470

  Otero, Miguel ^a   Calarota, Sandra A ^a   Dai, Anlan ^a   De Groot, Anne S ^b,c   Boyer, Jean D ^a   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BROWN UNIVERSITY   (United States)

^c EpiVax Inc   (United States)

Author keywords

Cellular and humoral immune responses; DNA vaccines; Smallpox

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; HLA A2 ANTIGEN; PLASMID DNA; SMALLPOX VACCINE; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VACCINE PRODUCTION; VACCINIA; VACCINIA VIRUS; VIRUS GENE;

ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; INTERFERON TYPE II; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMIDS; SMALLPOX VACCINE; VACCINES, DNA; VACCINIA VIRUS;

EID: 33747149959     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.010     Document Type: Article

References (38)

1. Rosenthal S.R., Merchlinsky M., Kleppinger C., and Goldenthal K.L. Developing new smallpox vaccines. Emerg Infect Dis 7 6 (2001) 920-926
2. Greenberg M. Complications of vaccination against smallpox. Am J Dis Child 76 (1948) 492-502
3. Neff J.M., Levine R.H., Lane J.M., Ager E.A., Moore H., Rosenstein B.J., et al. Complications of smallpox vaccination United States. II. Results obtained by four statewide surveys. Pediatrics 39 6 (1967) 916-923
4. Neff J.M., Lane J.M., Pert J.H., Moore R., Millar J.D., and Henderson D.A. Complications of smallpox vaccination. I. National survey in the United States. N Engl J Med 276 3 (1967) 125-132
5. Neff J.M., and Drachman R.H. Complications of smallpox vaccination, 1968 surveillance in a comprehensive care clinic. Pediatrics 50 3 (1972) 481-483
6. Lane J.M., and Millar J.D. Routine childhood vaccination against smallpox reconsidered. N Engl J Med 281 22 (1969) 1220-1224
7. Lane J.M., Ruben F.L., Neff J.M., and Millar J.D. Complications of smallpox vaccination. N Engl J Med 281 22 (1969) 1201-1208
8. Lane J.M., Ruben F.L., Neff J.M., and Millar J.D. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 122 4 (1970) 303-309
9. Fulginiti VA, Kempe CH, Hathaway WE, Pearlman DS, Sieber OF, Eller JJ, et al. Progressive vaccinia in immunologically deficient individuals. New York: The National Foundation-March of Dimes, Birth Defects, Original Article Series, Immunologic Deficiency Diseases in Man 1968;4:129-45.
10. Cangemi V.F. Acute pericarditis after smallpox vaccination. N Engl J Med 258 25 (1958) 1257-1259
11. Holtzman C.M. Postvaccination arthritis. N Engl J Med 280 2 (1969) 111-112
12. Marmelzat W.L. Malignant tumors in smallpox vaccination scars: a report of 24 cases. Arch Dermatol 97 4 (1968) 400-406
13. Copeman P.W., and Wallace H.J. Eczema vaccinatum. Br Med J 5414 (1964) 906-908
14. Lane J.M., Ruben F.L., Abrutyn E., and Millar J.D. Death attributable to smallpox vaccination, 1959 to 1966, and 1968. JAMA 212 3 (1970) 441-444
15. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y., et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90 9 (1993) 4156-4160
16. Haynes J.R., Fuller D.H., Eisenbraun M.D., Ford M.J., and Pertmer T.M. Accell particle-mediated DNA immunization elicits humoral, cytotoxic and protective responses. AIDS Res Hum Retroviruses 10 Suppl. 2 (1994) S43-S45
17. Lu S., Santoro J.C., Fuller D.H., Haynes J.R., and Robinson H.L. Use of DNAs expressing HIV-1 Env and non-infectious HIV-1 particles to raise antibody responses in mice. Virology 209 1 (1995) 147-154
18. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M.G., Gilbert L., Bagarazzi M.L., et al. Protection of chimpanzees from high dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 3 5 (1997) 526-532
19. Wang B., Merva M., Dang K., Ugen K.E., Boyer J.D., Williams W.V., et al. DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells. AIDS Res Hum Retroviruses 10 Suppl. 2 (1994) S35-S41
20. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.E., Lekutis C., et al. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA 94 17 (1997) 9378-9383
21. Yasutomi Y., Robinson H.L., Lu S., Mustafa F., Lekutis C., Arthos J., et al. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol 70 1 (1996) 678-681
22. MacGregor R.R., Boyer J.D., Ugen K.E., Lacy K.E., Bagarazzi M.L., Chattergoon M., et al. First human trial of a DNA-based vaccine for the treatment of HIV-1 infection: safety and host responses. J Infect Dis 178 1 (1998) 92-100
23. Calarota S., Bratt G., Nordlund S., Hinkula J., Leandersson A.C., Sandstrom E., et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351 9112 (1998) 1320-1325
24. Boyer J.D., Chattergoon M., Ugen K.E., Shah A., Bennett M., Cohen A., et al. Enhancement of cellular immune response in HIV-1 seropositive individuals: a DNA-based trial. Clin Immunol 90 1 (1999) 100-107
25. Calarota S.A., Leandersson A.C., Bratt G., Hinkula J., Klinman D.M., Weinhold K.J., et al. Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment. J Immunol 163 4 (1999) 2330-2338
26. MacGregor R.R., Ginsberg R., Ugen K.E., Baine Y., Kang C.U., Tu X.M., et al. T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev. AIDS 16 16 (2002) 2137-2143
27. Rodriguez J.F., and Esteban M. Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J Virol 61 11 (1987) 3550-3554
28. Demkowicz W.E., Maa J.S., and Esteban M. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J Virol 66 1 (1992) 386-398
29. Gordon J., Kovala T., and Dales S. Molecular characterization of a prominent antigen of the vaccinia virus envelope. Virology 167 2 (1988) 361-369
30. Maa J.S., and Esteban M. Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus. J Virol 61 12 (1987) 3910-3919
31. Kovacs G.R., and Moss B. The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression. J Virol 70 10 (1996) 6796-6802
32. Cudmore S., Blasco R., Vincentelli R., Esteban M., Sodeik B., Griffiths G., et al. A vaccinia virus core protein, p39, is membrane associated. J Virol 70 10 (1996) 6909-6921
33. Poland G.A., Grabenstein J.D., and Neff J.M. The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine 23 17-18 (2005) 2078-2081
34. Rodriguez J.F., Janeczko R., and Esteban M. Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J Virol 56 2 (1985) 482-488
35. Vazquez M.I., Rivas G., Cregut D., Serrano L., and Esteban M. The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal a-helix. J Virol 72 12 (1998) 10126-10137
36. Hooper J.W., Custer D.M., and Thompson E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 306 1 (2003) 1811-1895
37. Pulford D.J., Gates A., Bridge S.H., Robinson J.H., and Ulaeto D. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunization in protection of BALB/c mice from a lethal intranasal poxvirus challenge. Vaccine 22 25-26 (2004) 3358-3366
38. Hooper J.W., Thompson E., Wilhelmsen C., Zimmerman M., Ait Ichou M., Steffen S.E., et al. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol 78 9 (2004) 4433-4443